Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and Prognosis
NCT ID: NCT00819442
Last Updated: 2009-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2009-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure
NCT05770349
Influence of Severe Heart Failure to Function and Molecular Biological Parameters of Catabolism in the Human Diaphragm and Peripheral Skeletal Muscle
NCT02663115
Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy
NCT00480961
Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction
NCT02649400
Surgical Removal of Carotid Body in Patients With Systolic Heart Failure
NCT01653821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients without heart failure, with cardiobiopsy
cardiobiopsy
5 samples will be taken from right ventricle by Cordis bioptome
2
patients with heart failure in NYHA class I, II
cardiobiopsy
5 samples will be taken from right ventricle by Cordis bioptome
3
Patients with heart failure in NYHA class III, IV
cardiobiopsy
5 samples will be taken from right ventricle by Cordis bioptome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cardiobiopsy
5 samples will be taken from right ventricle by Cordis bioptome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* dilated left ventricle
* ejection fraction below 45%
Exclusion Criteria
* kidney failure (GFR \< 30, creatinine below 2,5 mg/dl
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Polish Academy of Sciences
OTHER
Ministry of Scientific Research and Information Technology, Poland
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Polish Academy of Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Hospital of Ministry of Internal Affairs and Administration
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N N402196135
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.